Celecoxib Prevents Cognitive Impairment and Neuroinflammation in Soluble Amyloid β-treated Rats

被引:51
作者
Mhillaj, Emanuela [1 ]
Morgese, Maria Grazia [2 ]
Tucci, Paolo [2 ]
Furiano, Anna [3 ]
Luongo, Livio [3 ]
Bove, Maria [2 ]
Maione, Sabatino [3 ]
Cuomo, Vincenzo [1 ]
Schiavone, Stefania [2 ]
Trabace, Luigia [2 ]
机构
[1] Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy
[2] Univ Foggia, Dept Clin & Expt Med, Via Napoli 20, I-71121 Foggia, Italy
[3] Univ Naples 2, Dept Expt Med, Naples, Italy
关键词
COX-2; soluble beta-amyloid; neuroinflammation; cognitive impairment; microglia; astrocytes; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; CYCLOOXYGENASE-2; COX-2; NEUROTROPHIC FACTOR; NEURODEGENERATIVE DISEASES; SYNAPTIC PLASTICITY; NATURAL OLIGOMERS; DOWN-REGULATION;
D O I
10.1016/j.neuroscience.2017.12.046
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Recent findings suggest that soluble forms of amyloid-beta (sA beta) peptide contribute to synaptic and cognitive dysfunctions in early stages of Alzheimer's disease (AD). On the other hand, neuroinflammation and cyclooxygenase-2 (COX-2) enzyme have gained increased interest as key factors involved early in AD, although the signaling pathways and pathophysiologic mechanisms underlying a link between sA beta-induced neurotoxicity and inflammation are still unclear. Here, we investigated the effects of selective COX-2 enzyme inhibition on neuropathological alterations induced by sA beta administration in rats. To this purpose, animals received an intracere-broventricular (icv) injection of predominantly monomeric forms of sA beta and, 7 days after, behavioral as well as biochemical parameters and neurotransmitter alterations were evaluated. During this period, rats also received a sub-chronic treatment with celecoxib. Biochemical results demonstrated that icv sA beta injection significantly increased both COX-2 and pro-inflammatory cytokines expression in the hippocampus (Hipp) of treated rats. In addition, the number of hypertrophic microglial cells and astrocytes were upregulated in sA beta-treated group. Interestingly, rats treated with sA beta showed long-term memory deficits, as confirmed by a significant reduction of discrimination index in the novel object recognition test, along with reduced brain-derived neurotrophic factor expression and increased noradrenaline levels in the Hipp. Systemic administration of celecoxib prevented behavioral dysfunctions, as well as biochemical and neurotransmitter alterations. In conclusion, our results suggest that sA beta neurotoxicity might be associated to COX-2-mediated inflammatory pathways and that early treatment with selective COX-2 inhibitor might provide potential remedies to counterbalance the sA beta-induced effects. (C) 2018 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:58 / 73
页数:16
相关论文
共 131 条
  • [1] Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial
    Aisen, PS
    Schafer, KA
    Grundman, M
    Pfeiffer, E
    Sano, M
    Davis, KL
    Farlow, MR
    Jin, S
    Thomas, RG
    Thal, LJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21): : 2819 - 2826
  • [2] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [3] [Anonymous], 2015, PLOS ONE
  • [4] The novel object recognition memory: neurobiology, test procedure, and its modifications
    Antunes, M.
    Biala, G.
    [J]. COGNITIVE PROCESSING, 2012, 13 (02) : 93 - 110
  • [5] Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis
    Bailey, Jason A.
    Maloney, Bryan
    Ge, Yuan-Wen
    Lahiri, Debomoy K.
    [J]. GENE, 2011, 488 (1-2) : 13 - 22
  • [6] Balducci C, 2016, BRAIN BEHAV IMMUNITY
  • [7] Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's disease
    Balducci, Claudia
    Frasca, Angelisa
    Zotti, Margherita
    La Vitola, Pietro
    Mhillaj, Emanuela
    Grigoli, Emanuele
    Iacobellis, Martina
    Grandi, Federica
    Messa, Massimo
    Colombo, Laura
    Molteni, Monica
    Trabace, Luigia
    Rossetti, Carlo
    Salmona, Mario
    Forloni, Gianluigi
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2017, 60 : 188 - 197
  • [8] Involvement of cyclooxygenase-2 in lipopolysaccharide-induced impairment of the newborn cell survival in the adult mouse dentate gyrus
    Bastos, G. N.
    Moriya, T.
    Inui, F.
    Katura, T.
    Nakahata, N.
    [J]. NEUROSCIENCE, 2008, 155 (02) : 454 - 462
  • [9] Expression and regulation of cyclooxygenase-2 in rat microglia
    Bauer, MKA
    Lieb, K
    SchulzeOsthoff, K
    Berger, M
    GebickeHaerter, PJ
    Bauer, J
    Fiebich, BL
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (03): : 726 - 731
  • [10] COX-2 as a multifunctional neuronal modulator
    Bazan, NG
    [J]. NATURE MEDICINE, 2001, 7 (04) : 414 - 415